title: Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat.
abstract: Hitherto, high-frequency local field potential oscillations in the upper gamma frequency band (40-80 Hz) have been recorded only from the region of subthalamic nucleus (STN) in parkinsonian patients treated with levodopa. Here we show that local field potentials recorded from the STN in the healthy alert rat also have a spectral peak in the upper gamma band (mean 53 Hz, range 46-70 Hz). The power of this high-frequency oscillatory activity was increased by 30 +/- 4% (+/-SEM) during motor activity compared to periods of alert immobility. It was also increased by 86 +/- 36% by systemic injection of the D2 dopamine receptor agonist quinpirole. The similarities between the high-frequency activities in the STN of the healthy rat and in the levodopa-treated parkinsonian human argue that this oscillatory activity may be physiological in nature and not a consequence of the parkinsonian state.
authors.affiliation: Sobell Department of Neurophysiology, Institute of Neurology, London, WCIN 3BG, United Kingdom.
authors.forename: Peter
authors.initials: P
authors.lastname: Brown
authors.forename: Andreas
authors.initials: A
authors.lastname: Kupsch
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Magill
authors.forename: Andrew
authors.initials: A
authors.lastname: Sharott
authors.forename: Daniel
authors.initials: D
authors.lastname: Harnack
authors.forename: Wassilios
authors.initials: W
authors.lastname: Meissner
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001683:Biological Clocks / Q000187:drug effects / Q000502:physiology*; D018491:Dopamine Agonists / Q000494:pharmacology; D020820:Dyskinesias / Q000150:complications / Q000503:physiopathology; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D019257:Quinpirole / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017448:Receptors, Dopamine D2 / Q000819:agonists; D012016:Reference Values; D012146:Rest / Q000502:physiology; D020531:Subthalamic Nucleus / Q000187:drug effects / Q000502:physiology*; D014851:Wakefulness / Q000502:physiology*
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D017448:Receptors, Dopamine D2; D019257:Quinpirole; D007980:Levodopa